AwardedAwarded 25 June 2026

Service and Maintenance Contract for Genomic Sequencing Platform

Northumbria University · Education

In brief

Northumbria University awarded this contract to Pacific Biosciences of California on 25 June 2026.

Built from the notice's own fields. Always check the official notice before you bid.

What the notice says

Northumbria University has procured a 5-year service, support, and maintenance contract for an existing Revio high-throughput genomic sequencing platform to support advanced molecular, environmental, and bioscience research frameworks within the Faculty of Science and Environment. This specialized multi-year service agreement is critical for ensuring the continuous, high-availability, and high-precision operational performance of complex, long-read sequencing instrumentation running critical data workflows. The contract ensures the systematic provisioning of vital maintenance parameters—including preventative maintenance visits, emergency engineering labor, certified replacement parts,…Read the full description
Northumbria University has procured a 5-year service, support, and maintenance contract for an existing Revio high-throughput genomic sequencing platform to support advanced molecular, environmental, and bioscience research frameworks within the Faculty of Science and Environment. This specialized multi-year service agreement is critical for ensuring the continuous, high-availability, and high-precision operational performance of complex, long-read sequencing instrumentation running critical data workflows. The contract ensures the systematic provisioning of vital maintenance parameters—including preventative maintenance visits, emergency engineering labor, certified replacement parts, proprietary consumables required for mechanical repairs, and real-time remote performance monitoring—allowing researchers to maximize instrument uptime and maintain strict data fidelity across high-throughput genomic pipelines. The contract is awarded via a formal internal procurement exemption as the sequencing platform relies entirely on proprietary technology and closed-source software architectures. Consequently, the original equipment manufacturer (OEM) is the sole authorized provider capable of supplying certified replacement parts, executing specialized engineering calibrations, and providing remote diagnostic support. No alternative provider exists with the technical capacity or legal authorization to service the asset without compromising instrument validation, operational warranties, or downstream research data fidelity.

Who won

WinnerValueDates
Pacific Biosciences of California£326,250
Awarded 10 June 2026
26 June 2026 to 22 May 2031

Values as the award notice gives them, excluding VAT where stated.

Timeline

  1. Transparency notice · UK5, notice 055419-2026
  2. Contract award notice · UK6, notice 055561-2026
  3. Contract details notice · UK7, notice 063106-2026

About the buyer

Procurements

15

Awards

12

Suppliers it has used most

From notice 055419-2026 on Find a Tender, first published 11 June 2026, last updated 6 July 2026. We last checked for changes on 28 September 2026.